NCT01346475View on ClinicalTrials.gov

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

September 30, 2011

Conditions
Genital Herpes
Interventions
DRUG

valacyclovir

1000 mg orally three times daily for 5 weeks

DRUG

Valacyclovir

500 mg orally once daily for 5 weeks

Trial Locations (1)

98104

University of Washington Virology Research Clinic, Seattle

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Washington

OTHER